Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

Cited by (1,000)

Items 401–500 of 1,000

1. α7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1
   Shiny Mathew, Amanda J. Law, Barbara K. Lipska, Martha I. Dávila‐García, Eduardo D. Zamora, Shruti N. Mitkus, Radhakrishna Vakkalanka, Richard E. Straub, Daniel R. Weinberger, Joel E. Kleinman et al. · 2007 · Human Molecular Genetics
2. Tabac et schizophrénie : aspects épidémiologiques et cliniques
   Alain Dervaux, Xavier Laqueille · 2008 · L Encéphale
3. Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of α7 nicotinic acetylcholine receptors
   Kenji Hashimoto, Masaomi Iyo, Robert Freedman, Karen E. Stevens · 2005 · Psychopharmacology
4. Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome
   Steven H. Laval, J. C. Dann, R.J. Butler, Joséphine Loftus, Judith E. Rue, Sarah Leask, Nicholas James Bass, Margherita Comazzi, Antonio Vita, S. Nanko et al. · 1998 · American Journal of Medical Genetics
5. A CHRNA5 allele related to nicotine addiction and schizophrenia
   Liyi Elliot Hong, Xiaochun Yang, Ikwunga Wonodi, Colin A. Hodgkinson, David A Goldman, Oscar Colin Stine, Elliot A. Stein, Gunvant K. Thaker · 2011 · Genes Brain & Behavior
6. Nicotine and familial vulnerability to schizophrenia: A discordant twin study.
   Michael J. Lyons, Jessica L. Bar, William S. Kremen, Rosemary Toomey, Seth A. Eisen, Jack H. Goldberg, Stephen V. Faraone, Ming T. Tsuang · 2002 · Journal of Abnormal Psychology
7. Chapter 2. Neuroscience Research Agenda to Guide Development of a Pathophysiologically Based Classification System
   Dennis S. Charney, David Harrison Barlow, Kelly N. Botteron, Jonathan D. Cohen, David A Goldman, Raquel E. Gur, Keh‐Ming Lin, Juan F. López, James H. Meador‐Woodruff, Steven O. Moldin et al. · 2002 · American Psychiatric Association Publishing eBooks
8. Endophenotyping schizotypy: a prelude to genetic studies within the schizophrenia spectrum
   Kristin S. Cadenhead, DAVID L. BRAFF · 2002 · Schizophrenia Research
9. Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia
   Douglas Blackwood, Mike F. Glabus, Julie R. Dunan, Ronan E. O’Carroll, Walter J. Muir, Klaus P. Ebmeier · 1999 · The British Journal of Psychiatry
10. Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the α7 nicotinic acetylcholine receptor: In vitro and in vivo activity
    Brad A. Acker, E. Jon Jacobsen, Bruce N. Rogers, Donn G. Wishka, Steven C. Reitz, David W. Piotrowski, Jason K. Myers, Mark L. Wolfe, Vincent E. Groppi, Bruce A. Thornburgh et al. · 2008 · Bioorganic & Medicinal Chemistry Letters
11. Do Nicotinic Receptors Modulate High-Order Cognitive Processing?
    Fani Koukouli, Jean‐Pierre Changeux · 2020 · Trends in Neurosciences
12. Allosteric Transitions of the Acetylcholine Receptor
    Stuart J. Edelstein, Jean‐Pierre Changeux · 1998 · Advances in protein chemistry
13. Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia
    Hong Lin, Fu‐Chun Hsu, Bailey H. Baumann, Douglas A. Coulter, Stewart A. Anderson, David R. Lynch · 2014 · Molecular and Cellular Neuroscience
14. D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia
    Alok K Sharma, M L Kramer, P F Wick, D Liu, Sunitha Chari, S Shim, W Tan, D Ouellette, M Nagata, Curtiss J. DuRand et al. · 1999 · Molecular Psychiatry
15. Neuronal Nicotinic Acetylcholine Receptors: Involvement in Alzheimer’s Disease and Schizophrenia
    Diana S. Woodruff‐Pak, Thomas J. Gould · 2002 · Behavioral and Cognitive Neuroscience Reviews
16. Comparative analysis of cholinergic innervation in the dorsal hippocampus of adult mouse and rat: A quantitative immunocytochemical study
    Nicolas Aznavour, Naguib Mechawar, Laurent Descarries · 2002 · Hippocampus
17. Decreased Amphetamine-Induced Locomotion and Improved Latent Inhibition in Mice Mutant for the M5 Muscarinic Receptor Gene Found in the Human 15q Schizophrenia Region
    Haoran Wang, Karen Ka Yan Ng, Dave J. Hayes, Xiangrong Gao, Gina L. Forster, Charles D. Blaha, John S. Yeomans · 2004 · Neuropsychopharmacology
18. Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome
    Kristin S. Cadenhead · 2002 · Psychiatric Clinics of North America
19. Nicotinic Modulation of Mesoprefrontal Dopamine Neurons: Pharmacologic and Neuroanatomic Characterization
    Tony Peter George, Christopher D. Verrico, Marina R. Picciotto, Robert Howard Roth · 2000 · Journal of Pharmacology and Experimental Therapeutics
20. [11C]CHIBA-1001 as a Novel PET Ligand for α7 Nicotinic Receptors in the Brain: A PET Study in Conscious Monkeys
    Kenji Hashimoto, Shingo Nishiyama, Hiroyuki Ohba, Masaaki Matsuo, Tatsuhiko Kobashi, Makoto Takahagi, Masaomi Iyo, Takeru Kitashoji, Hideo Tsukada · 2008 · PLoS ONE
21. Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP)
    Joseph F. Cubells, Richard Feinn, Deborah Pearson, Jeffrey M. Burda, Yi‐lang Tang, Lindsay A. Farrer, Joel E. Gelernter, Henry R. Kranzler · 2005 · Drug and Alcohol Dependence
22. Convergence and Divergence in the Neurochemical Regulation of Prepulse Inhibition of Startle and N40 Suppression in Rats
    Neal R. Swerdlow, Mark A. Geyer, Jody M. Shoemaker, Gregory A. Light, DAVID L. BRAFF, Karen E. Stevens, Richard F. Sharp, Michelle R. Breier, Alaina C. Neary, Pamela P. Auerbach · 2005 · Neuropsychopharmacology
23. Beta (∼16 Hz) frequency neural oscillations mediate auditory sensory gating in humans
    Liyi Elliot Hong, Robert W. Buchanan, Gunvant K. Thaker, Paul D. Shepard, Ann T. Summerfelt · 2007 · Psychophysiology
24. Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life
    Xiao-Hong Li, Feng‐Rong An, Gabor Sandor Ungvari, Chee H. Ng, Helen F.K. Chiu, Ping-Ping Wu, Xin Jin, Yu‐Tao Xiang · 2017 · Scientific Reports
25. Genetics of Posttraumatic Stress Disorder
    Ronnen H. Segman, Arieh Y. Shalev · 2003 · CNS Spectrums
26. Searching for schizophrenia genes
    Nicholas J. Bray, Michael John Owen · 2001 · Trends in Molecular Medicine
27. Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
    Darlene H. Brunzell, Alexandra M. Stafford, Claire I. Dixon · 2015 · Current Addiction Reports
28. Sensory gating and source analysis of the auditory P50 in low and high suppressors
    Verner Knott, Anne Millar, Derek J. Fisher · 2008 · NeuroImage
29. Delayed hemodynamic responses in schizophrenia
    Judith M. Ford, Matthew B. Johnson, Susan Whitfield‐Gabrieli, William O. Faustman, Daniel H. Mathalon · 2005 · NeuroImage
30. Applications of functional magnetic resonance imaging in psychiatry
    Martina T. Mitterschiffthaler, Ulrich Ettinger, Mitul Ashok Mehta, David Mataix‐Cols, Steven Williams · 2006 · Journal of Magnetic Resonance Imaging
31. Factor structure and heritability of endophenotypes in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS-1)
    Larry J. Seidman, Gerhard Hellemann, Keith H. Nuechterlein, Tiffany A. Greenwood, DAVID L. BRAFF, Kristin S. Cadenhead, Monica E. Calkins, Robert Freedman, Raquel E. Gur, Ruben C. Gur et al. · 2015 · Schizophrenia Research
32. Effects of Nicotine Vary Across Two Auditory Evoked Potentials in the Mouse
    Kayla L. Metzger, Christina R. Maxwell, Yuling Liang, Steven J. Siegel · 2006 · Biological Psychiatry
33. Modeling Heterogeneous Patients With a Clinical Diagnosis of Schizophrenia With Induced Pluripotent Stem Cells
    Kristen Brennand, Melissa A. Landek‐Salgado, Akira Sawa · 2013 · Biological Psychiatry
34. Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex
    Éliane Proulx, Matthew Piva, Michael K. Tian, Craig D. C. Bailey, Evelyn K. Lambe · 2013 · Cellular and Molecular Life Sciences
35. Male fetus susceptibility to maternal inflammation: C-reactive protein and brain development
    Sharon K. Hunter, Maria Camille Hoffman, Angelo D’Alessandro, Kathleen Noonan, Anna Wyrwa, Robert Freedman, Amanda J. Law · 2019 · Psychological Medicine
36. Performance of α7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task
    Jason J. Keller, Ashleigh B. Keller, Barbara J. Bowers, Jeanne M. Wehner · 2005 · Behavioural Brain Research
37. Slow Cortical Potentials in Migraine Families
    Michael Siniatchkin, Ellen Kirsch, Peter A. Kropp, Ulrich Stephani, W.D. Gerber · 2000 · Cephalalgia
38. The effect of state on sensory gating: comparison of waking, REM and non-REM sleep
    Michael A. Kisley, Ann Olincy M. D, Robert Freedman · 2001 · Clinical Neurophysiology
39. Solution Structure of α-Conotoxin ImI by1H Nuclear Magnetic Resonance
    John Gehrmann, Norelle L. Daly, Paul F. Alewood, David J. Craik · 1999 · Journal of Medicinal Chemistry
40. Recent advances in the genetics of schizophrenia
    Dawn M. Waterworth, Anne S. Bassett, Linda M. Brzustowicz · 2002 · Cellular and Molecular Life Sciences
41. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects
    JANUSZ K. RYBAKOWSKI, Alina Borkowska, Piotr M. Czerski, Joanna Hauser · 2001 · Molecular Psychiatry
42. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia
    Taryn G. Moss, Kristi A. Sacco, Taryn M. Allen, Andrea H. Weinberger, Jennifer C. Vessicchio, Tony Peter George · 2009 · Drug and Alcohol Dependence
43. Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future
    Maaike Alaerts, Jurgen Del‐Favero · 2009 · Human Mutation
44. Prenatal Primary Prevention of Mental Illness by Micronutrient Supplements in Pregnancy
    Robert Freedman, Sharon K. Hunter, Maria Camille Hoffman · 2018 · American Journal of Psychiatry
45. Visual hallucinations are associated with lower αbungarotoxin binding in dementia with Lewy bodies
    JENNIFER A. COURT, Clive G. Ballard, Margaret Ann Piggott, M Johnson, John Tiernan O'Brien, Clive Holmes, Nigel J. Cairns, Peter L Lantos, Robert H. Perry, Evelyn Jaros et al. · 2001 · Pharmacology Biochemistry and Behavior
46. Schizophrenia and tobacco smoking in a Spanish psychiatric hospital
    Adrián LLerena, A DELARUBIA, Eva Peñas‐Lledó, Francisco J. Díaz, J DELEON · 2002 · Schizophrenia Research
47. Finding Suitable Phenotypes for Genetic Studies of Schizophrenia: Heritability and Segregation Analysis
    Maartje F. Aukes, Behrooz Z. Alizadeh, Margriet Maria Sitskoorn, Jean‐Paul Selten, Richard J. Sinke, Chantal Kemner, Roel A. Ophoff, René S. Kahn · 2008 · Biological Psychiatry
48. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats
    Agnieszka Nikiforuk, Tomasz Kos, Małgorzata Hołuj, Agnieszka Potasiewicz, Piotr Popik · 2015 · Neuropharmacology
49. Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
    Cecilia Gotti, Eric Carbonnelle, Milena Moretti, Ruud Zwart, Francesco Clementi · 2000 · Behavioural Brain Research
50. Linkage analysis of schizophrenia to chromosome 15
    Pablo V. Gejman, Alan R. Sanders, Judith Ann Badner, Qiuhe Cao, Jing Zhang · 2001 · American Journal of Medical Genetics
51. Cigarette Smoking and Cognitive Function in Chinese Male Schizophrenia: A Case-Control study
    Xiangyang Zhang, Da Chun Chen, Mei Hong Xiu, Colin N. Haile, Hongqiang Sun, Lin Lü, Therese A. Kosten, Thomas R. Kosten · 2012 · PLoS ONE
52. NEURODEVELOPMENTAL AND NEUROPROGRESSIVE PROCESSES IN SCHIZOPHRENIA
    John L. Waddington, Abbie Lane, Paul J. Scully, Conall Larkin, Eadbhard O’Callaghan · 1998 · Psychiatric Clinics of North America
53. Evidence for a neurophysiologic auditory deficit in children with benign epilepsy with centro-temporal spikes
    Alki C. Liasis, Doris‐Eva Bamiou, Stewart G. Boyd, Anthony Towell · 2005 · Journal of Neural Transmission
54. Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker
    Kenji Hashimoto · 2015 · Current Pharmaceutical Design
55. Neurobiological Determinants of Tobacco Smoking in Schizophrenia
    Aliya M. Lucatch, Darby J. E. Lowe, Rachel C. Clark, Karolina Kozak, Tony Peter George · 2018 · Frontiers in Psychiatry
56. Meta-analysis of auditory P50 sensory gating in schizophrenia and bipolar disorder
    Murat İlhan Atagün, Marjan Drukker, Mei‐Hua Hall, İlkay Keleş Altun, Safiye Zeynep Tatlı, Sinan Gülöksüz, Jim van Os, Thérèse van Amelsvoort · 2020 · Psychiatry Research Neuroimaging
57. Neurophysiological Biomarkers in Schizophrenia—P50, Mismatch Negativity, and TMS-EMG and TMS-EEG
    Helena Kyunghee Kim, Daniel M. Blumberger, Zafiris Jeff Daskalakis · 2020 · Frontiers in Psychiatry
58. Sensory gating deficits in schizophrenia: can we parse the effects of medication, nicotine use, and changes in clinical status?
    Gregory A. Light, DAVID L. BRAFF · 2003 · Clinical Neuroscience Research
59. A Novel Permutation Testing Method Implicates Sixteen Nicotinic Acetylcholine Receptor Genes as Risk Factors for Smoking in Schizophrenia Families
    Stephen V. Faraone, Jessica Ann Lasky-Su, Levi Taylor, Marsha Wilcox, Paul Van Eerdewegh, Ming T. Tsuang · 2004 · Human Heredity
60. Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system
    Nicolas Champtiaux, Jean‐Pierre Changeux · 2004 · Progress in brain research
61. Cholinergic Agonists as Novel Treatments for Schizophrenia: The Promise of Rational Drug Development for Psychiatry
    Jeffrey Alan Lieberman, Jonathan A. Javitch, Holly M Moore · 2008 · American Journal of Psychiatry
62. [3H]A-585539 [(1 S,4 S)-2,2-Dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a Novel High-Affinity α7 Neuronal Nicotinic Receptor Agonist: Radioligand Binding Characterization to Rat and Human Brain
    David J. Anderson, William H. Bunnelle, Bruce W. Surber, Jia Yan Du, Carol S. Surowy, Eliane Tribollet, Anouk Marguerat, Daniel Bertrand, Murali Gopalakrishnan · 2007 · Journal of Pharmacology and Experimental Therapeutics
63. Failure to Find P50 Suppression Deficits in Young First-Episode Patients With Schizophrenia and Clinically Unaffected Siblings
    Odette Brand-de Wilde, Lo J. Bour, Peter M. A. J. Dingemans, Johannes H.T.M. Koelman, DON H. LINSZEN · 2006 · Schizophrenia Bulletin
64. Emerging Opportunities for Antipsychotic Drug Discovery in the Postgenomic Era
    Michael J. Marino, Lars J. S. Knutsen, Michael R. Williams · 2008 · Journal of Medicinal Chemistry
65. Nature and nurture in neuropsychiatric genetics: where do we stand?
    Danielle M. Dick, Brien P. Riley, Kenneth S. Kendler · 2010 · Dialogues in Clinical Neuroscience
66. Regulation of α7‐nicotinic receptor subunit and α7‐like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia
    Vincenzo De Luca, Olga Likhodi, Hubert H.M. Van Tol, James L. Kennedy, Albert H.C. Wong · 2006 · Acta Psychiatrica Scandinavica
67. Familial transmission of risk factors in the first-degree relatives of schizophrenic people
    Merilyne C. Waldo, Lawrence E. Adler, Sherry S. Leonard, Ann Olincy M. D, Randal G. Ross, Josette G. Harris, Robert Freedman · 2000 · Biological Psychiatry
68. Endophänotypen—ein neues Konzept zur biologischen Charakterisierung psychischer Störungen
    Astrid W. Zobel, Wolfgang Maier · 2004 · Der Nervenarzt
69. The new genetics of schizophrenia
    Colm McDonald, Kieran C. Murphy · 2003 · Psychiatric Clinics of North America
70. QT Interval Prolongation in Patients on Methadone With Concomitant Drugs
    Valerie Piguet, Jules Alexandre Desmeules, Georg Ehret, Rudolf Stoller, Pierre Dayer · 2004 · Journal of Clinical Psychopharmacology
71. Genetic bases for endophenotypes in psychiatric disorders
    Wade H. Berrettini · 2005 · Dialogues in Clinical Neuroscience
72. α-Bungarotoxin Receptors Contain α7 Subunits in Two Different Disulfide-Bonded Conformations
    Sergey Rakhilin, Renaldo C. Drisdel, Daphna Sagher, Daniel S. McGehee, Yolanda F. Vallejo, William N. Green · 1999 · The Journal of Cell Biology
73. Schizophrenia: A unique translational opportunity in behavioral neuroendocrinology
    James I. Koenig · 2006 · Hormones and Behavior
74. Novel α7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia
    Emily G. Severance, Robert H. Yolken · 2007 · Genes Brain & Behavior
75. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia
    Xiaohong Hong, Raymond C. K. Chan, Xi-Hang Zhuang, Tingyun Jiang, Xiaona Wan, Junqing Wang, Bo Xiao, Hanhui Zhou, Liyun Jiang, Bilan Weng · 2008 · Schizophrenia Research
76. Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective α7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders
    Anatoly A. Mazurov, David C. Kombo, Terry A. Hauser, Lan Miao, Gary M. Dull, John F. Genus, Nikolai B. Fedorov, Lisa Benson, Serguei S. Sidach, Yun-De Xiao et al. · 2012 · Journal of Medicinal Chemistry
77. Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia
    Ikwunga Wonodi, Robert P. McMahon, Nithin Krishna, Braxton D. Mitchell, Judy Liu, Matthew Glassman, Liyi Elliot Hong, James M. Gold · 2014 · Schizophrenia Research
78. Functional somato‐dendritic α7‐containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex
    Rebecca C. Klein, Jerrel L. Yakel · 2006 · The Journal of Physiology
79. Chromosome 22 workshop report
    Sibylle G. Schwab, Dieter B. Wildenauer, David Andrew Collier, A. Ekelund, Pablo V. Gejman, Joachim Franz Hallmayer, John R. Kelsoe, A. von Gontard, D.B. Wildenauer · 1999 · American Journal of Medical Genetics
80. Mechanics of Channel Gating of the Nicotinic Acetylcholine Receptor
    Xinli Liu, Yechun Xu, Honglin Li, Xicheng Wang, Hualiang Jiang, Francisco José Barrantes · 2008 · PLoS Computational Biology
81. Event-related potentials to auditory stimuli in female Vietnam nurse veterans with posttraumatic stress disorder
    Linda J. Metzger, Margaret A. Carson, Lynn A. Paulus, Natasha B. Lasko, Stephen R. Paige, Roger K. Pitman, Scott P. Orr · 2002 · Psychophysiology
82. Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders
    Lee, Chien-Hsing, Hung, Shih-Ya · 2022 · Pharmaceutics
83. Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia
    Jason R. Tregellas, Ann Olincy M. D, Lynn L. Johnson, Jody Tanabe, Shireen Shatti, Laura Martín, Debra Singel, Yiping P. Du, Ferenc S. Soti, William R. Kem et al. · 2009 · Neuropsychopharmacology
84. REVIEW: Cognitive effects of nicotine: genetic moderators
    Aryeh I. Herman, Mehmet Sofuoglu · 2010 · Addiction Biology
85. A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment
    Simon R. O. Nilsson, Pau Celada, Kim Fejgin, Jonas Thelin, Jacob Nielsen, Noemí Santana, Christopher J. Heath, Peter H. Larsen, Vibeke Nielsen, Brianne A. Kent et al. · 2016 · Psychopharmacology
86. Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis
    Rafael Segarra, Arantzazu Zabala, J.I. Eguíluz, Natalia Ojeda, Edorta Elizagárate, Pedro Sánchez, Javier Ballesteros, Miguel Gutiérrez · 2010 · European Archives of Psychiatry and Clinical Neuroscience
87. The molecular genetics of schizophrenia: an emerging consensus
    Stephen V. Faraone, Levi Taylor, Ming T. Tsuang · 2002 · Expert Reviews in Molecular Medicine
88. Components of the smooth pursuit function in deficit and nondeficit schizophrenia
    Liyi Elliot Hong, Matthew T. Avila, Helene M. Adami, Amie Elliott, Gunvant K. Thaker · 2003 · Schizophrenia Research
89. Closing in on Genes for Manic-Depressive Illness and Schizophrenia
    Elliot S. Gershon · 1998 · Neuropsychopharmacology
90. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History
    Tiffany A. Greenwood, Gregory A. Light, Neal R. Swerdlow, Monica E. Calkins, Michael Foster Green, Raquel E. Gur, Ruben C. Gur, Laura C. Lazzeroni, Keith H. Nuechterlein, Ann Olincy M. D et al. · 2015 · American Journal of Psychiatry
91. Recent advances in treating cognitive impairment in schizophrenia
    Cherrie Ann Galletly · 2008 · Psychopharmacology
92. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties
    M. S. Thomsen, R. Zwart, D. Ursu, M. M. Jensen, L. Pinborg, G. Gilmour, Jie Wu, E. Sher, J. Mikkelsen · 2015 · PLoS ONE
93. Episodic Memory Performance Predicted by the 2bp Deletion in Exon 6 of the “Alpha 7-Like” Nicotinic Receptor Subunit Gene
    Emma Louise Dempster, Timothea Toulopoulou, Colm McDonald, Elvira Bramon, Muriel Walshe, Harvey Wickham, Pak Chung Sham, Robin M. Murray, David Andrew Collier · 2006 · American Journal of Psychiatry
94. Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy
    Florian Ferreri, Catherine Agbokou, Serge G. Gauthier · 2006 · Journal of Psychiatry and Neuroscience
95. Schizophrenia endophenotypes as treatment targets
    Gunvant K. Thaker · 2007 · Expert Opinion on Therapeutic Targets
96. Schizophrenia, antipsychotics and diabetes: Genetic aspects
    Frank Bellivier · 2005 · European Psychiatry
97. Delaminating myelin membranes help seal the cut ends of severed earthworm giant axons
    Martis L. Ballinger, Adam R. Blanchette, Todd L. Krause, Mark E. Smyers, Harvey M. Fishman, George D. Bittner · 1997 · Journal of Neurobiology
98. Genetic psychophysiology: Advances, problems, and future directions
    Andrey P. Anokhin · 2014 · International Journal of Psychophysiology
99. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists
    Yu Xue, Jingshu Tang, Xiaozhuo Ma, Qing Li, Bingxue Xie, Yuchen Hao, Hongwei Jin, KeWei Wang, Guisen Zhang, Liangren Zhang et al. · 2016 · European Journal of Medicinal Chemistry
100. Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development
     Robert Freedman, Sharon K. Hunter, Amanda J. Law, Brandie D. Wagner, Angelo D’Alessandro, Uwe Christians, Kathleen Noonan, Anna Wyrwa, Maria Camille Hoffman · 2019 · The Journal of Pediatrics